Fierce Pharma
JUNE 3, 2024
Following fellow immunotherapy regimens by Roche and AstraZeneca, Bristol Myers Squibb’s Opdivo and Yervoy want to carve out a piece of the first-line liver cancer market, too. | Following fellow immunotherapy regimens by Roche and AstraZeneca, Bristol Myers Squibb’s Opdivo and Yervoy want to carve out a piece of the first-line liver cancer market, too.
MedCity News
JUNE 3, 2024
The large-scale, multidisciplinary effort to improve the performance of pulse oximeters provides an example of the value of collaboration to solve problems and shows how industry partners can contribute in a significant way when they have a seat at the table. The post Collaboration is Vital to Creating Inclusive Healthcare Technologies appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 3, 2024
The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim—vulnera | The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim—vulnerable to costly awards, settlements and litigation fees as they try to resolve claims that the heartburn
MedCity News
JUNE 3, 2024
Singling out an industry segment won’t solve the underlying problem of healthcare costs. The post The Senate Attacks on Pharma Put the Industry in Jeopardy and Consumers at Risk appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JUNE 3, 2024
Thanks to a shortage of the isotope actinium, RayzeBio has temporarily halted new patient enrollment in its phase 3 study in neuroendocrine tumors.
pharmaphorum
JUNE 3, 2024
GSK planning to refile anti-BCMA drug Blenrep in the US for multiple myeloma after reporting positive results from the DREAMM-8 trial at ASCO
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JUNE 3, 2024
AstraZeneca's ASCO 'super sunday' delivers new data for Tagrisso and Imfinzi in lung cancer and Enhertu in breast cancer
Fierce Pharma
JUNE 3, 2024
As Japanese chemical giant Asahi Kasei continues its foray into the biopharma contract manufacturing space, the company’s biologics CDMO is expanding its offerings to include starting materials for | Asahi’s U.S. subsidiary Bionova Scientific is launching a new business line to provide services around plasmid DNA (pDNA), the companies announced Monday.
MedCity News
JUNE 3, 2024
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced in May. The post 5 Funding Announcements Made By Payer/Employer Companies In May appeared first on MedCity News.
pharmaphorum
JUNE 3, 2024
Shares in GSK plummet after Delaware court says litigation claiming Zantac can cause cancer is cleared to go ahead
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Commerce
JUNE 3, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
JUNE 3, 2024
Moderna has secured approval from the US Food and Drug Administration (FDA) for mRESVIA (respiratory syncytial virus vaccine).
European Pharmaceutical Review
JUNE 3, 2024
A report by Spherical Insights has predicted that the process spectroscopy market will value $35.8 billion by 2033. Process spectroscopy is becoming more connected to automation and digitalisation initiatives, like Industry 4.0, the report stated. The analytical technique can therefore aid smart production and predictive maintenance. Furthermore, incorporating data analytics and artificial intelligence (AI) facilitates predictive process control and optimisation, the report explained.
PharmaTimes
JUNE 3, 2024
The platform will be used to diagnose and treat cancers, including lung and brain tumours
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
JUNE 3, 2024
The contest — which will include startup focusing on pediatric and teen behavioral health — will take place at Pegasus Park in Dallas on September 18. The deadline to submit applications is July 10, so apply today! The post To All Pediatric and Teen Mental Health Startups Seeking Investors: Apply for MedCity’s Pitch Perfect Contest! appeared first on MedCity News.
PharmaTimes
JUNE 3, 2024
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy
PharmaTech
JUNE 3, 2024
Pharmaceutical Technology® spoke with Jeff Clement, executive director of Technical Sales for Development and Manufacturing Group at PCI Pharma Services, about the challenges and benefits of incorporating robotics into aseptic manufacturing.
PharmaVoice
JUNE 3, 2024
Cancer vaccines are taking off in the clinic, and a partnership between Merck and Moderna is at the forefront of a new wave of immunotherapy.
PharmaTech
JUNE 3, 2024
The PharmTech Group spoke with Stacey Treichler, senior director of Marketing and Strategy for Purolite at Ecolab, about the impact of advanced therapies, new innovations, and sustainability on the biopharmaceutical industry.
Pharmaceutical Technology
JUNE 3, 2024
The choice of control means that a US or European approval for Ambrx's ARX788 may not be possible based on ACE-Breast-02 study data.
PharmaVoice
JUNE 3, 2024
Jim Lang, CEO of Eversana, explains the shifting commercial environment and how past drug launch failures are informing the future.
Pharmaceutical Technology
JUNE 3, 2024
The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) are uniting to create a single online source for credible cancer information.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
JUNE 3, 2024
Promises of sexual improvement may ensnare unsuspecting patients with potentially dangerous adverse effects from untested OTC remedies.
PharmaTech
JUNE 3, 2024
Webinar Date/Time: Thursday, June 20, 2024 - 11am EDT | 4pm GMT | 5pm CEST
Pharmacy Times
JUNE 3, 2024
Data analysis can help hospitals address waste of controlled substances that fuels diversion and increased costs.
PharmaTech
JUNE 3, 2024
Improved efficiencies and reduced costs are clear advantages of automating drug manufacturing processes.
Pharmacy Times
JUNE 3, 2024
Patients with sickle cell disease with more than a 6-month delay transitioning from pediatric to adult care were about twice as likely to be hospitalized.
PharmExec
JUNE 3, 2024
Results of the ADRIATIC trial indicated that treatment with Imfinzi after standard-of-care concurrent chemoradiotherapy improves overall survival and progression-free survival in patients with limited-stage small cell lung cancer.
Pharmacy Times
JUNE 3, 2024
Daratumumab in combination with standard treatment regimens shows benefit in multiple myeloma.
PharmExec
JUNE 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
304 
Let's personalize your content